RARE (STOCKS)
Ultragenyx Pharmaceutical Inc.
$23.850000
-0.350000 (-1.45%)
Prev close: $24.200000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Emil D. Kakkis
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,304.75M
- Employees
- 1,294
- P/E (TTM)
- -4.02
- P/B (TTM)
- 251.00
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Assets | $1.19B |
| Current Assets | $643.21M |
| Inventory | $52.20M |
| Other Current Assets | $591.01M |
| Noncurrent Assets | $547.24M |
| Fixed Assets | $249.96M |
| Intangible Assets | $172.94M |
| Other Non-current Assets | $124.34M |
| Liabilities | $1.17B |
| Current Liabilities | $340.02M |
| Accounts Payable | $40.57M |
| Wages | $84.39M |
| Other Current Liabilities | $215.06M |
| Noncurrent Liabilities | $834.26M |
| Equity | $9.16M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.16M |
| Temporary Equity | $7.00M |
| Liabilities And Equity | $1.19B |